U.S. Markets close in 1 hr 35 mins
  • S&P 500

    3,827.15
    -73.64 (-1.89%)
     
  • Dow 30

    30,749.83
    -503.30 (-1.61%)
     
  • Nasdaq

    11,092.53
    -295.96 (-2.60%)
     
  • Russell 2000

    1,741.18
    -35.05 (-1.97%)
     
  • Crude Oil

    113.15
    +0.94 (+0.84%)
     
  • Gold

    1,840.90
    -0.30 (-0.02%)
     
  • Silver

    21.65
    -0.26 (-1.20%)
     
  • EUR/USD

    1.0540
    -0.0048 (-0.4532%)
     
  • 10-Yr Bond

    2.7900
    -0.0650 (-2.28%)
     
  • Vix

    31.60
    +2.25 (+7.67%)
     
  • GBP/USD

    1.2463
    -0.0012 (-0.0972%)
     
  • USD/JPY

    127.8220
    +0.0280 (+0.0219%)
     
  • BTC-USD

    28,855.46
    -1,371.36 (-4.54%)
     
  • CMC Crypto 200

    642.43
    -30.94 (-4.60%)
     
  • FTSE 100

    7,389.98
    +87.24 (+1.19%)
     
  • Nikkei 225

    26,739.03
    +336.19 (+1.27%)
     

IRIDEX's (NASDAQ:IRIX) investors will be pleased with their impressive 194% return over the last year

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

IRIDEX Corporation (NASDAQ:IRIX) shareholders might be concerned after seeing the share price drop 16% in the last quarter. But that doesn't change the fact that the returns over the last year have been very strong. During that period, the share price soared a full 194%. So we think most shareholders won't be too upset about the recent fall. Investors should be wondering whether the business itself has the fundamental value required to continue to drive gains.

Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns.

See our latest analysis for IRIDEX

Given that IRIDEX didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually expect strong revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

In the last year IRIDEX saw its revenue grow by 42%. We respect that sort of growth, no doubt. While that revenue growth is pretty good the share price performance outshone it, with a lift of 194% as mentioned above. If the profitability is on the horizon then now could be a very exciting time to be a shareholder. Of course, we are always cautious about succumbing to 'fear of missing out' when a stock has shot up strongly.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

earnings-and-revenue-growth
earnings-and-revenue-growth

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

A Different Perspective

We're pleased to report that IRIDEX shareholders have received a total shareholder return of 194% over one year. There's no doubt those recent returns are much better than the TSR loss of 9% per year over five years. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. It's always interesting to track share price performance over the longer term. But to understand IRIDEX better, we need to consider many other factors. Take risks, for example - IRIDEX has 3 warning signs we think you should be aware of.

We will like IRIDEX better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.